Tradestie Institutional Equity Comparison Engine

TBPH vs ANL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TBPH Overall Edge

TBPH Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Theravance Biopharma, Inc. (TBPH) driven by superior Valuation, Growth & Margin, Options & Structure while ANL counters with relative strength in Momentum & Technical. Fundamentally, TBPH trades at 13.4x Forward P/E with 8.9% operating margin (-20.9% YoY revenue) versus ANL at N/M Forward P/E and -123.5% operating margin (+178.1% YoY). In options structure, TBPH sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro) against ANL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner TBPH
TBPH 13.4x vs ANL N/M Fwd P/E
Growth & Margin Winner TBPH
Op Margin 8.9% vs -123.5% ยท YoY -20.9% vs +178.1%
Momentum & Technical Winner ANL
1Y +21.0% vs +560.3% ยท 52W Pos 50% vs 56%
Options & Structure Winner TBPH
UNCLASSIFIED (16th %ile IV) vs UNCLASSIFIED (N/A IV)
TBPH NASDAQ
Theravance Biopharma, Inc.
Pharmaceutical Preparations
$17.03
+0.0% 1D
Market Cap $884.2M
1M Return +0.12%
1Y Return +21.04%
Forward P/E 13.4x
Unified AI Score
54.9 / 100 HOLD
Tech 65.0 Fund 52.0 Flow 50.0 Mom 35.0
ANL US Equity
ANL
Institutional Equity
$9.97
-6.03% 1D
Market Cap $677.5M
1M Return -9.61%
1Y Return +560.26%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TBPH +21.04% ANL +560.26% Spread: +948.18 pp (ANL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TBPH TTM Op. Margin: 8.9% ANL TTM Op. Margin: -123.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TBPH vs ANL. Trailing 12-month operating profitability (TBPH 8.9% vs ANL -123.5%) and valuation multiples (TBPH 13.4x vs ANL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TBPH (8) vs ANL (2)
Institutional Metric TBPH ANL Criterion Row Winner
Market Capitalization Scale $884.2M $677.5M Larger Scale TBPH
Trailing P/E Ratio Valuation 16.4x N/M Lower Multiple TBPH
Forward P/E Ratio Valuation 13.4x N/M Lower Multiple TBPH
Revenue Growth (YoY) Growth -20.9% +178.1% Higher Growth ANL
Operating Margin (TTM) Profitability 8.9% -123.5% Higher Margin TBPH
Net Profit Margin Profitability 51.6% -124.8% Higher Margin TBPH
Return on Equity (ROE) Capital Efficiency 20.9% -20.2% Higher ROE TBPH
52-Week Range Position Momentum 50% ($13โ€“$21) 56% ($1โ€“$17) Stronger Trend ANL
Beta / 30D Volatility Risk Regime 0.48ฮฒ ยท 2% Vol 2.61ฮฒ ยท 79% Vol Lower Realized Risk TBPH
Unified Institutional Score Composite Signal 54.9 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite TBPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TBPH vs ANL Buy Guide
TBPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live TBPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ANL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TBPH nor ANL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.